01
Understand A Company
Review approved statements, filings, transcripts, research, and events. Keep each statement linked to its source.
Connect investment research, financial data, portfolio context, events, and human review. Mimasa helps teams search approved sources, analyse information, monitor change, and prepare decision-ready briefs.
Use AI agents to organise evidence and repeatable work. Keep every investment, risk, allocation, and trade decision with authorised professionals.
Ask a question | Gather evidence | Compare investments | Monitor events | Prepare review

Good research starts with a defined question. It should not begin with an AI-generated conclusion.
01
Review approved statements, filings, transcripts, research, and events. Keep each statement linked to its source.
02
Apply consistent fields, periods, definitions, and assumptions. Show missing or non-comparable information.
03
Connect performance, exposure, risk, position, and event information. Separate measured facts from interpretation.
04
Track configured indicators against an approved thesis. A signal prompts review, not an automatic trade.
05
Assemble sources, analysis, questions, risks, scenarios, and prior decisions for authorised review.
Mimasa helps teams research and review. It does not tell people what to buy or sell.
Investment research gathers and analyses information about companies, securities, markets, sectors, funds, or other approved investments.
The work can include statements, filings, transcripts, licensed research, news, market information, portfolio data, and internal views.
Mimasa connects this evidence with analysis and workflow. Investment teams remain responsible for methods, conclusions, and decisions.
Approved filings, statements, and company reports, labelled by entity, period, date, and source.
Authorised earnings calls, presentations, and commentary, with each speaker statement kept distinct from verified facts.
Licensed research, approved news, industry information, and market sources with attribution and access rules.
Permitted holdings, exposures, benchmarks, risk measures, prior decisions, and monitoring rules.
Analyst notes, assumptions, questions, approvals, and committee outcomes kept separate from source facts.
This structure supports financial research without weakening evidence standards.
Equity research can involve company performance, financial position, commentary, industry conditions, risks, and valuation inputs.
The system can prepare a first analysis. An analyst confirms its interpretation and relevance. Price targets or recommendations stay within authorised internal sources and permissions.
Financial statement analysis software can calculate ratios and trends. Useful research also preserves period, accounting basis, units, currency, restatements, and source notes.
Investment analysis may combine this evidence with approved methods. AI financial analysis can draft an explanation, but it must not invent a cause.
Earnings call analysis can surface statements, recurring topics, guidance changes, questions, and business drivers.
A summary retains attribution and links to the passage. Tone alone cannot support an investment conclusion.
Financial news analysis has the highest reported volume in the supplied research. Its keyword difficulty is 100, so it supports the page rather than leading it.
01
Receive permitted news and event data from approved sources.
02
Connect the event with the correct company, security, sector, theme, or exposure.
03
Apply configured event types and relevance rules. Show uncertainty and ambiguity.
04
Retrieve related filings, financials, prior events, notes, and portfolio information.
05
Route the event to an authorised analyst for interpretation.
06
Preserve the source, date, review, decision, and next monitoring step.
News sentiment does not predict price direction. An event is evidence for review, not an automatic trade signal.
Portfolio intelligence connects approved portfolio information with research, events, performance, risk, and workflow status.
Lens 01
Approved return and contribution measures by period, portfolio, strategy, asset, or another permitted dimension.
Lens 02
Authorised risk, concentration, exposure, and scenario measures with method and date visible.
Lens 03
Material filings, news, earnings calls, internal reviews, and configured monitoring events.
Lens 04
Open research, pending reviews, overdue tasks, decisions, and reporting status.
Each lens supports drill-down. A complex portfolio should never become an unexplained score.
Portfolio monitoring tracks configured investment, risk, performance, event, and workflow information over time.
Portfolio performance monitoring links approved measures to the relevant period and method. It never promises future results.
Where sources update at different times, the delay stays visible.
Portfolio monitoring software should explain why something changed and what review follows.
Investment monitoring software may already own positions or records. Mimasa adds intelligence and orchestration around connected systems.
Portfolio analytics can compare performance, exposure, concentration, risk, attribution, and other approved measures. Each needs a defined method and period.
Portfolio analytics software may calculate specialist measures. Asset management analytics can add strategy, mandate, fund, client, or operating views where permitted.
| Analytical Question | Required Context | Control |
|---|---|---|
| What drove portfolio change? | Period, holdings, flows, prices, method, and benchmark | Confirm source and calculation basis |
| Where is exposure concentrated? | Entity, sector, geography, currency, theme, or factor | Use approved classifications |
| Which events affect holdings? | Entity links, source dates, relevance rules, and portfolio mapping | Analyst confirms relevance |
| How did the portfolio compare? | Approved benchmark, period, and return method | Avoid unsupported performance claims |
| What needs review? | Materiality rule, questions, task owner, and deadline | Human review before action |
Portfolio risk analytics uses approved measures to understand risk, exposure, concentration, or scenario effects.
Investment risk analytics can flag threshold proximity, selected risk contributors, scenario changes, stale inputs, and reviews awaiting an owner.
Results show their method, date, assumptions, and coverage. They are not certain predictions.
Investment risk analytics software is the lowest-difficulty commercial opportunity in the supplied research.
Portfolio risk analytics software can supply specialist measures. Mimasa connects approved outputs without replacing a validated risk engine.
Portfolio attribution analysis explains performance through an approved method. Results change with benchmark, classification, period, currency, and approach.
Mimasa can ingest an approved output or apply a configured, validated method. It can prepare commentary linked to supporting data.
Attribution does not prove manager skill or predict future performance.
Investment research software should move from a question to evidence, analysis, review, and a reusable record. Useful investment research tools preserve that chain instead of returning an unsupported answer.
Investment analysis software often focuses on calculation, screening, or modelling. Mimasa adds document intelligence, portfolio context, agents, and controlled workflows.
An investment analytics platform should connect data, methods, evidence, and decisions without becoming a black box.
Mimasa orchestrates authorised sources where rights and integration are configured. It does not supply every underlying data set.
Financial data analysis tools are useful when teams understand the data behind each result.
Mimasa can standardise authorised inputs and preserve lineage across questions, dashboards, and reports.
Original and prepared values
Source and reporting period
Entity and security mapping
Currency and unit treatment
Formula or approved method
Missing and conflicting data
Reviewer and version
Portfolio reporting automation can collect approved information, refresh tables, prepare charts, draft commentary, and route review. It cannot invent explanations or remove sign-off.
01
Choose the portfolio, audience, period, template, and approved measures.
02
Retrieve authorised holdings, performance, risk, events, research, and workflow status.
03
Build tables and charts. Draft commentary from available evidence.
04
Highlight missing inputs, changed definitions, variances, and unsupported statements.
05
Route the report to authorised reviewers and permitted channels.
06
Keep the source snapshot, version, comments, approval, and final output.
Use a modular brief builder instead of a long document preview.
AI can prepare the first draft. An authorised professional owns the final content and recommendation.
The system preserves the sources used at the time of review.
Searches authorised documents, data, research, and news. It returns sources with the answer.
Applies configured calculations and comparisons. It exposes methods, inputs, and missing information.
Watches approved sources for configured events and routes relevant changes to an analyst.
Connects research with permitted holdings, exposures, performance, risk, and prior reviews.
Prepares a brief, report, or presentation from approved information and requests review before publication.
Each agent needs approved sources, defined methods, role and tool permissions, confidence thresholds, completion rules, human review, and an audit history.
Build Governed AI AgentsInvestment data and research can be sensitive, licensed, and market-moving. Access and action need clear control.
The organisation remains responsible for data rights, research policy, regulation, governance, and decisions. Mimasa does not guarantee compliance.
Operational measures show process quality. They do not prove investment performance.
Start with one question, source set, analyst group, and output. Expand only after controls work as intended.
Design Governed Agentic Workflows01
Choose one repeatable question, approved source set, analyst group, and output.
02
Document access, licensing, retention, citation, and distribution rules.
03
Map companies, securities, portfolios, periods, currencies, metrics, and definitions.
04
Define what AI may retrieve, calculate, summarise, monitor, and draft.
05
Test stale reports, conflicts, restatements, ambiguity, missing periods, and unsupported claims.
06
Review citations, analyst corrections, missed events, access failures, and adoption.
07
Add portfolios, sources, methods, and outputs after validating the current scope.
Move from a summary to the document, data point, passage, date, and method.
Connect company research with approved holdings, exposure, performance, risk, and prior decisions.
Route changes with evidence, questions, ownership, and deadlines.
Use agents for retrieval, analysis, monitoring, and drafting while professionals control conclusions.
Preserve the evidence snapshot, draft changes, approvals, and final output.
Operate in cloud, private-cloud, or on-premises environments according to enterprise needs.
Mimasa is an intelligence and workflow layer. It is not an investment adviser, broker, trading platform, portfolio accountant, market-data provider, or research publisher.
Connect cash positions, forecasts, scenarios, and treasury review.
Match financial, investment, cash, and settlement records.
Connect deal materials, evidence, review findings, and portfolio-company information.
Adviser preparation and governed client communication.
Evidence, configured controls, and tracked findings.
Clear answers about investment research, portfolio intelligence, monitoring, reporting, evidence, and human control.
Connect approved research, financial data, portfolios, AI agents, reports, and human review. Start with one defined research workflow.